I did see that and guessed as much.
My head is spinning with the RMAT news on LVAD/CHF. I didn't expect it so soon. If this gets conditional approval in 2018, we are potentially looking at a USD 15 billion market cap. And I think that's a conservative estimate. And it will come much sooner than most of us expected.
Can I technically ask Santa for another wish since this came 4 days before Christmas ?
Ann: Mesoblast Receives RMAT For LVAD Heart Failure Patients, page-72
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |